Kelso Pharma Group gather in Edinburgh for All Company meeting
Last week, members of the Kelso Pharma Group from across the globe travelled to Scotland’s capital, Edinburgh, for an insightful and engaging all company meeting. With presentations from Kelso Pharma board members and senior management as well as break out sessions, it offered the opportunity for Kelso Pharma, Stirling Anglian Pharmaceuticals and Velit Biopharma teams […]
Kelso Pharma appoints UK Managing Director
Kelso Pharma, the growing UK based specialty pharma business, has appointed senior pharmaceutical executive, Mark Inker, as its first UK Managing Director. A pharmaceutical company director with over 30 years’ experience in commercialisation of pharmaceutical and medical device products, Mark has built a strong track record for growing businesses in the sector. His mix of […]
Apposite Capital-backed Kelso Pharma acquires Stirling Anglian Pharmaceuticals
Apposite Capital, the healthcare specialist private equity investor, and Kelso Pharma today announce the acquisition of Stirling Anglian Pharmaceuticals Limited. Kelso Pharma is headed by Dr Tom Stratford, previously CEO of Kyowa Kirin International (“KKI”), the European and US business arm of Kyowa Kirin, which purchased Scottish Borders based ProStrakan Group PLC in 2011. He […]
